Status:
UNKNOWN
Self-administered Acupressure to Improve Cancer-related Fatigue Among Cancer Patients Undergoing Chemotherapy
Lead Sponsor:
The University of Hong Kong
Conditions:
Cancer, Breast
Fatigue
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary aim of the study is to determine whether self-administered acupressure has effects equivalent to aerobic exercise on CRF in cancer patients undergoing chemotherapy. Secondary outcomes incl...
Detailed Description
Cancer-related fatigue (CRF) is recognized as the most frequently reported and distressing symptom among cancer patients. CRF is particularly prevalent in patients undergoing chemotherapy, reported to...
Eligibility Criteria
Inclusion
- aged 18 or above
- with a diagnosis of breast cancer
- scheduled to commence their first cycle of outpatient adjuvant chemotherapy
- have an Eastern Cooperative Oncology Group performance status of 0 or 1
- screened as no contraindications for exercise based on a pre-exercise safety assessment (including aspects of blood results, cardiorespiratory signs and symptoms, metastasis, and variations in cognitive functions)
- written informed consent
Exclusion
- have received/self-administered acupressure or acupuncture in the previous 3 months
- have engaged in \>90 min of moderate intensity aerobic exercise per week in the previous 3 months
- are pregnant or lactating
- have any injury or ulcers around the acupoints
- unable to communicate in Cantonese, Mandarin, or English
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT05409352
Start Date
June 1 2022
End Date
May 1 2025
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong